Designed with or without integrated fixation and options to gain up to 30 degrees of angulation, the implant can be adjusted intra-operatively, to fit each patient’s needs.
FDA approved an expansion to its Phase I/II clinical program to include three spinal fusion indications and tripling the number of investigational sites in the U.S.
The new MC insert is designed to enhance total knee replacement performance by incorporating features that better replicate natural knee function and motion.
Agreements include a distribution contract for SAFE Orthopaedics' implants and instruments and a production contract for development of future products.